75,411 resources
By Version
By Authority
By Realm
Start Prev Rows 57200 - 57400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
|---|---|---|---|---|---|---|---|---|---|
| kl.dk.fhir.ffinst | R4 | ValueSet/FindingInformerCodes | FindingInformerCodes | active | 2023-08 | dk | |||
| kl.dk.fhir.children | R4 | ValueSet/FindingInformerCodes | KildeTilOplysningKoder | active | 2024-10 | dk | |||
| hl7.terminology | R5 | ValueSet/research-study-reason-stopped | ResearchStudyReasonStopped | draft | 1 | brr | 2020-02 | uv | hl7 |
| botswana.hie.fhir | R5 | ValueSet/vs-master-facility-list-codes | Master Facility List (MFL) Codes | active | 2025-05 | ||||
| de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | ValueSet/vs-rating-certainty-of-evidence | Rating Certainty Of Evidence | draft | 2022-09 | uv | hl7 | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | ValueSet/vs-rating-concern-degree | Rating Concern Degree | draft | 2022-09 | uv | hl7 | ||
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splColor | SPL Color | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splComboProductType | SPL Combo Product Type | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splDoseForm | SPL Dose Form | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splFlavor | SPL Flavor | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splMarketingCategories | SPL Marketing Categories | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splOperationType | SPL Operation Type | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splPackageTypes | SPL Package Types | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splRouteOfAdministration | SPL Route of Administration | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splShape | SPL Shape | trial-use | 1 | brr | 2025-07 | us | hl7 |
| hl7.fhir.us.spl | R5 | ValueSet/valueset-splSpecialMeasures | SPL Special Measures | trial-use | 1 | brr | 2025-07 | us | hl7 |
| il.core.fhir.r4 | R4 | ValueSet/reason-not-done | statusReason codes for Immunization profile | active | il | national | |||
| il.core.fhir.r4 | R4 | ValueSet/immunization-side-effect | Immunization side-effect codes | active | il | national | |||
| vcds-ig.euvabeco.net | R5 | ValueSet/NUVA | NUVA codes | draft | 2025-08 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-tnm-m-kategorie | MII VS Onkologie TNM M Kategorie | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-tnm-n-kategorie | MII VS Onkologie TNM N Kategorie | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-tnm-t-kategorie | MII VS Onkologie TNM T Kategorie | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-grading | MII VS Onkologie Grading | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-primaertumor-diagnosesicherung | MII VS Onkologie Primärtumor Diagnosesicherung | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-seitenlokalisation | MII VS Onkologie Primärtumor Seitenlokalisation | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-tnm-version | MII VS Onkologie TNM Version | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-tnm-cp-praefix | MII VS Onkologie TNM cpu Praefix | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-tnm-klassifikation-typ | MII VS Onkologie TNM Klassifikation Typ | active | de | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-icdo3-topographie | MII VS Onkologie ICD-O-3 Topographie | active | de | ||||
| kbv.ita.aws | R4 | ValueSet/KBV_VS_AW_Vermittlungsart | KBV_VS_AW_Vermittlungsart | active | 2018-10 | ||||
| de.medizininformatikinitiative.kerndatensatz.onkologie | R4 | ValueSet/mii-vs-onko-icdo3-morphologie | MII VS Onkologie ICD-O-3 Morphologie | active | de | ||||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/coded-test-results-athena-vs | Coded test results: Athena. | draft | 2025-07 | eu | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/cancer-histology-behavior-athena-vs | Cancer histology behaviour: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/cancer-histology-subgroup-athena-vs | Cancer histology subgroup: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.fhir.uv.saner | R4 | ValueSet/AllCOVID19RiskFactors | All COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/COVID19Complications | COVID-19 Complications | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/VTEReports | Codes for reports about VTE Diagnosics | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.uv.saner | R4 | ValueSet/IsolationPrecautions | COVID-19 Isolation Precautions | active | pher | 2024-05 | uv | hl7 | |
| hl7.fhir.us.davinci-crd | R4 | ValueSet/cdsHookType | CDS Hook Types Value Set | trial-use | 4 | fm | 2025-08 | us | hl7 |
| hl7.terminology | R5 | ValueSet/parameter-group | DeviceDefinitionParameterGroup | draft | oo | 2020-02 | uv | hl7 | |
| hl7.terminology | R5 | ValueSet/v3-NationEntityType | NationEntityType | active | 2014-03 | uv | hl7 | ||
| hl7.fhir.uv.saner | R4 | ValueSet/SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 | active | pher | 2024-05 | uv | hl7 | |
| hl7.eu.fhir.idea4rc | R4 | ValueSet/HNC-condition-athena-vs | HNC ConditionList: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/cancer-diagnosis-athena-vs | Cancer Diagnosis: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/sarcome-list-athena-vs | Sarcome List: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/cancer-histology-athena-vs | Cancer histology: Athena | draft | 2025-07 | eu | hl7 | ||
| signal.core.r4 | R4 | ValueSet/chargeitem-status | ChargeItemStatus | trial-use | 0 | pa | 2019-10 | us | hl7 |
| hl7.terminology | R5 | ValueSet/definition-status | DefinitionStatus | draft | fhir | 2020-02 | uv | hl7 | |
| signal.core.r4 | R4 | ValueSet/invoice-status | InvoiceStatus | trial-use | 0 | fm | 2019-10 | us | hl7 |
| hl7.fhir.uv.ae-research-backport-ig | R4 | ValueSet/adverse-event-status-vs | Adverse Event Status | informative | brr | 2024-04 | uv | hl7 | |
| signal.core.r4 | R4 | ValueSet/event-status | EventStatus | trial-use | 3 | fhir | 2019-10 | us | hl7 |
| signal.core.r4 | R4 | ValueSet/request-status | RequestStatus | draft | 3 | pc | 2019-10 | us | hl7 |
| hl7.eu.fhir.idea4rc | R4 | ValueSet/cancer-event-type-vs | Disease Status: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | ValueSet/metastasis-disorder-athena-vs | Metastatis: Athena | draft | 2025-07 | eu | hl7 | ||
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-myeloma-iss-stage-value-vs | International Staging System (ISS) for Myeloma Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-myeloma-riss-stage-value-vs | Revised International Staging System (ISS) for Multiple Myeloma Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-all-risk-assessment-value-vs | Acute Lymphoblastic Leukemia (ALL) Risk Assessment Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-binet-stage-value-vs | Binet Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-neuroblastoma-INRGSS-value-vs | International Neuroblastoma Risk Group Staging System (INRGSS) for Neuroblastoma Risk Assessment Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-pretext-stage-value-vs | PRETEXT Stage Value | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-rai-stage-value-vs | Rai Stage Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-international-retinoblastoma-stage-value-vs | International Retinoblastoma Stage Value | active | cic | 2025-02 | us | hl7 | |
| ch.fhir.ig.ch-emed-epr | R4 | ValueSet/ch-emed-epr-substance-admin-substitution-code | Substance Administration Substitution Codes | draft | 2025-01 | ch | hl7 | ||
| ca.on.phsd.r4-alpha | R4 | ValueSet/wait-time-range | Wait Time Range | draft | |||||
| hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIPMOConsentCategoriesVS | Portable Medical Order Categories | trial-use | 2 | pe | 2025-08 | us | hl7 |
| hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIAttesterRoleTypeVS | Attester Role | trial-use | 2 | pe | 2025-08 | us | hl7 |
| hl7.fhir.us.physical-activity | R4 | ValueSet/pa-task-status | PA Task Fulfillment Status | trial-use | 2 | pc | 2024-03 | us | hl7 |
| hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIHCADecisionsVS | Healthcare Agent Decisions | trial-use | 2 | pe | 2025-08 | us | hl7 |
| us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) | active | 2008-01 | us | |||
| hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTAdjustmentReasonVS | PCT Adjustment Reason | trial-use | fm | 2025-08 | us | hl7 | |
| hl7.fhir.us.illTraveler | R4 | ValueSet/InfectiousDiseaseVS | Infectious Disease VS | draft | 2024-03 | us | hl7 | ||
| signal.core.r4 | R4 | ValueSet/request-intent | RequestIntent | draft | 3 | oo | 2019-10 | us | hl7 |
| signal.core.r4 | R4 | ValueSet/invoice-priceComponentType | InvoicePriceComponentType | trial-use | 0 | fm | 2019-10 | us | hl7 |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-wilms-tumor-body-site-vsCOG | Wilms Tumor Body Site Value Set | active | cic | 2025-02 | us | hl7 | |
| fhir.paciosampledata | R4 | ValueSet/MAPProblemPriorityVS | Medical Action Plan Problem Priority | draft | 2025-07 | us | hl7 | ||
| MyHIE.v4-test | R4 | ValueSet/value-set-task-business-status-my-core | ValueSetTaskBusinessStatus (MY Core) | active | 2023-07 | ||||
| IdHIE.0v | R4 | ValueSet/value-set-task-business-status-id-core | ValueSetTaskBusinessStatus (ID Core) | active | 2023-06 | ||||
| uk.nhsdigital.r4.test | R4 | ValueSet/a6876ad9-6ac5-431a-980d-b093a07e84d6 | NHSDigital Task Code | draft | 2022-03 | hl7 | |||
| hl7.terminology | R5 | ValueSet/payeetype | Payee Type Codes | active | 1 | fm | 2024-04 | uv | hl7 |
| hl7.fhir.us.mcode | R4 | ValueSet/mcode-deauville-scale-vs | Deauville Scale Value Set | active | cic | 2025-02 | us | hl7 | |
| hl7.terminology | R5 | ValueSet/goal-acceptance-status | GoalAcceptanceStatus | draft | pc | 2020-02 | uv | hl7 | |
| hl7.fhir.cz.lab | R4 | ValueSet/cz-lab-clinically-relevant-time-VS | ValueSet - Clinically Relevant Time | active | 2025-07 | cz | hl7 | ||
| hl7.fhir.us.physical-activity | R4 | ValueSet/pa-observation-code-activity | PA Observation Activity-related codes | trial-use | 2 | pc | 2024-03 | us | hl7 |
| ca.on.oh-olis | R4 | ValueSet/olis-RequestPriority | RequestPriority | active | hl7 | ||||
| hl7.fhir.us.core | R4 | ValueSet/us-core-observation-smoking-status-status | US Core Status for Smoking Status Observation | trial-use | 3 | cgp | 2022-09 | us | hl7 |
| signal.core.r4 | R4 | ValueSet/observation-status | ObservationStatus | normative | 5 | oo | 2019-10 | us | hl7 |
| hl7.terminology | R5 | ValueSet/variant-state | sequenceStatus | draft | cg | 2020-02 | uv | hl7 | |
| rapportendoscopiequebec.test | R4 | ValueSet/ca-qc-endo-valueset-impressionconclusionendo | ImpressionConclusionEndo | active | 2024-05 | ||||
| hl7.terminology | R5 | ValueSet/v3-ActInvoiceAdjudicationPaymentCode | ActInvoiceAdjudicationPaymentCode | active | 2014-03 | uv | hl7 | ||
| hl7.terminology | R5 | ValueSet/v3-ActInvoiceAdjudicationPaymentSummaryCode | ActInvoiceAdjudicationPaymentSummaryCode | active | 2014-03 | uv | hl7 | ||
| hl7.fhir.ca.baseline | R4 | ValueSet/ethnicitycode | EthnicityCode | draft | 2019-09 | ca | hl7 | ||
| hl7.terminology | R5 | ValueSet/v3-ActInvoiceDetailCode | ActInvoiceDetailCode | active | 2014-03 | uv | hl7 | ||
| hl7.terminology | R5 | ValueSet/v3-ActInvoiceAdjudicationPaymentGroupCode | ActInvoiceAdjudicationPaymentGroupCode | active | 2014-03 | uv | hl7 | ||
| us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.828 | Country | active | 2018-01 | us | |||
| us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.829 | County | active | 2019-01 | us | |||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de165 | 75 g oral glucose tolerance test (OGTT) - 1 hour | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de166 | 75 g oral glucose tolerance test (OGTT) - 2 hours | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de164 | 75 g oral glucose tolerance test (OGTT) - fasting glucose | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de72 | Abdominal exam result - Abdominal exam result not done Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de74 | Abdominal exam result - Mass/tumour Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de73 | Abdominal exam result - Normal abdominal exam result Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de78 | Abdominal exam result - Other abnormal abdominal exam result (specify) Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de76 | Abdominal exam result - Pain on deep palpation Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de75 | Abdominal exam result - Pain on superficial palpation Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de77 | Abdominal exam result - Painful decompression Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de71 | Abdominal exam result | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b6-de58 | Allergies Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b6-de57 | Allergies | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de10 | Amniotic fluid level Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de9 | Amniotic fluid level | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de188 | Anaemia diagnosis Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de187 | Anaemia diagnosis | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-c-de5 | Any treatment given before referral | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de157 | Asymptomatic bacteriuria (ASB) diagnosis Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de156 | Asymptomatic bacteriuria (ASB) diagnosis | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de15 | Average weight gain per week | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de4 | BMI | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-end-23 | Birth weight | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de160 | Blood glucose test ordered | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de168 | Blood glucose test result | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de162 | Blood glucose test type | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de175 | Blood haemoglobin test conducted | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de176 | Blood haemoglobin test ordered | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de186 | Blood haemoglobin test result | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de178 | Blood haemoglobin test type Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de177 | Blood haemoglobin test type | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de22 | Blood pressure cannot be taken | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de25 | Blood type Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de24 | Blood type | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b9-de22 | Blood type test conducted | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de34 | Body temperature | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de68 | Breast exam result - Bleeding Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de62 | Breast exam result - Breast exam not done Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de65 | Breast exam result - Discharge Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de66 | Breast exam result - Flushing Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de69 | Breast exam result - Increased temperature Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de67 | Breast exam result - Local pain Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de64 | Breast exam result - Nodule Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de63 | Breast exam result - Normal breast exam result Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de70 | Breast exam result - Other breast exam result (specify) Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de61 | Breast exam result | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de57 | Cardiac exam result - Arrhythmia Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de56 | Cardiac exam result - Bradycardia Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de51 | Cardiac exam result - Cardiac exam not done Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de59 | Cardiac exam result - Cold sweats Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de53 | Cardiac exam result - Heart murmur Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de52 | Cardiac exam result - Normal cardiac exam result Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de60 | Cardiac exam result - Other abnormal cardiac exam result (specify) Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de58 | Cardiac exam result - Peripheral cyanosis Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de55 | Cardiac exam result - Tachycardia Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de54 | Cardiac exam result - Weak pulse Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de50 | Cardiac exam result | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-end-41 | Cause of death Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-end-40 | Cause of death | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de93 | Cervical dilation | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de92 | Cervical exam conducted | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b8-de121 | Clinical enquiry for IPV | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b6-de145 | Clinical enquiry for alcohol and other substance use done | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-a-de14 | Co-habitants Choices | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-a-de13 | Co-habitants | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b6-de161 | Contraceptive use of female condoms | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b6-de160 | Contraceptive use of male condoms | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de134 | Counsel to immediately go to the hospital if severe danger signs are present | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de78 | Counselling conducted on HIV positive | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de125 | Counselling conducted on HIV risk | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de181 | Counselling conducted on Hep B negative | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de142 | Counselling conducted on Rh factor negative | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de87 | Counselling conducted on TB screening positive | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de136 | Counselling conducted on birth preparedness and complications readiness | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de164 | Counselling conducted on breastfeeding | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de89 | Counselling conducted on diabetes mellitus (DM) | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de88 | Counselling conducted on gestational diabetes mellitus (GDM) | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de79 | Counselling conducted on hepatitis B positive | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de80 | Counselling conducted on hepatitis C positive | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de77 | Counselling conducted on hypertension | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de143 | Counselling conducted on intrapartum antibiotic to prevent early neonatal Group B Streptococcus (GBS) infection | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de241 | Counselling conducted on malaria prevention | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de242 | Counselling conducted on malaria prevention | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de133 | Counselling conducted on seeking care when danger signs occur | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de135 | Counselling on ANC contact schedule conducted | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de17 | Counselling on Alcohol Substance Abuse | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de18 | Counselling on Alcohol Substance Abuse | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de33 | Counselling on Antacid Preparations to Relieve Heartburn | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de34 | Counselling on Antacid Preparations to Relieve Heartburn | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de69 | Counselling on Balanced Energy and Protein Dietary Supplementation | draft | 2025-06 | uv | who | ||
| smart.who.int.anc | R4 | ValueSet/anc-b10-de70 | Counselling on Balanced Energy and Protein Dietary Supplementation | draft | 2025-06 | uv | who |